Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

AUPH Aurinia Pharmaceuticals

7.820
+0.340+4.55%
Trading Session 09/28 15:06 ET
High
7.840
Open
7.530
Turnover
5.57M
Low
7.530
Pre Close
7.480
Volume
724.83K
Market Cap
1.11B
P/E(TTM)
Loss
52wk High
33.972
Shares
141.89M
P/E(Static)
Loss
52wk Low
6.280
Float Cap
1.07B
Bid/Ask %
-42.86%
Historical High
33.972
Shs Float
136.92M
Volume Ratio
0.38
Historical Low
1.000
Dividend TTM
--
Div Yield TTM
--
P/B
2.62
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.53%
Amplitude
4.14%
Avg Price
7.686
Lot Size
1
Float Cap
1.07B
Bid/Ask %
-42.86%
Historical High
33.972
Shs Float
136.92M
Volume Ratio
0.38
Historical Low
1.000
Dividend TTM
--
P/B
2.62
Dividend LFY
--
Turnover Ratio
0.53%
Amplitude
4.14%
Avg Price
7.686
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
CEO: Mr. Peter S. Greenleaf
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...